| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700512 | Clinical Radiology | 2017 | 11 Pages |
Abstract
FDG PET/CT brain imaging has a significant clinical impact when performed selectively in patients with cognitive impairment and shows high accuracy in the diagnosis of AD in “real-world” clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
![Clinical impact and diagnostic accuracy of 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomography/computed tomography (PET/CT) brain imaging in patients with cognitive impairment: a tertiary centre experience in the UK](/preview/png/5700512.png "First Page Preview: Clinical impact and diagnostic accuracy of 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomography/computed tomography (PET/CT) brain imaging in patients with cognitive impairment: a tertiary centre experience in the UK")
Authors
H. Motara, T. Olusoga, G. Russell, S. Jamieson, S. Ahmed, N. Brindle, A. Pillai, A.F. Scarsbrook, C.N. Patel, F.U. Chowdhury,